Theriva Biologics Announces Appointment of Ramon Alemany, Ph.D., to Senior Vice President of Discovery
-Appointment expected to aid advancement of Theriva’s discovery program and strengthen collaboration with the Institut…
-Appointment expected to aid advancement of Theriva’s discovery program and strengthen collaboration with the Institut…
-Appointment expected to aid advancement of Theriva’s discovery program and strengthen collaboration with the Institut…
REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
GeneType featured on the Balancing Act Balance Act Set with Dr. Carolynn Young and Dr….
GeneType featured on the Balancing Act Balance Act Set with Dr. Carolynn Young and Dr….
First FGF21 analog to enter Phase 3 development SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE)…
First FGF21 analog to enter Phase 3 development SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE)…
Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer…
Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer…
The Company Has Received a Portion of the Final Milestone Payment, With a Value of…
The Company Has Received a Portion of the Final Milestone Payment, With a Value of…
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global…
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global…
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
PURCHASE, N.Y., May 23, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company”…
PURCHASE, N.Y., May 23, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company”…